Glaucoma Touch MEdical MEdia 99 Glaucoma is a leading cause of blindness worldwide. 1 Broadly speaking, there are two types of glaucoma: open angle and angle closure. Unlike open angle where the angle between the iris and cornea is open, angleclosure glaucoma is an optic neuropathy secondary to raised intraocular pressure (IOP) due to the closure of the drainage angle. Worldwide, the mean prevalence of angle closure glaucoma is 0.69 %, and 86 % of those affected were from Asia. 1 Although angle closure is less common, it is potentially more blinding, though early intervention could prevent progression of disease. Patients with acute angle closure often present with acute red painful eye but symptoms of chronic angle closure are often silent. Angle closure is classified according to gonioscopy findings, IOP, and optic nerve damage (see Table 1). Laser in angle closure has been used since the 1970s, and its application had expanded and evolved over the years. 2 This article reviews the type of lasers used in primary angle closure glaucoma (PACG), their efficacy, and complications.
Laser Peripheral Iridotomy Indications and EfficacyLaser peripheral iridotomy (LPI) is a treatment that creates an opening in the peripheral iris to allow an alternative pathway for aqueous to flow between the anterior and posterior chamber, bypassing the pupil. This eliminates the element of pupil block, which is the most common contributing factor to angle closure in PACG. 3 There are many other factors that contribute to the narrowing of the drainage angle, which includes lens vault, cataract, axial length, iris root thickness, and plateau iris configuration. 4 LPI is indicated in acute ACG (AACG), in the fellow eye of AACG, PAC suspects (PACS), PAC, and PACG (see Table 1). There is some evidence that LPI can be helpful in phacomorphic glaucoma and pigment dispersion syndrome. 3The effectiveness of LPI in preventing glaucoma, controlling IOP, and improving angle width, varies according to severity of disease at presentation as well as mechanism underlying angle closure. LPI is successful in preventing acute PAC (APAC) in the fellow eye of patients who had APAC. When followed up over 4 years, none of the fellow eyes treated with LPI developed APAC while only 11.2 % of cases had an increase in IOP during follow-up, which required additional medical or surgical intervention. 5 LPI can also be useful in controlling IOP and angle width. 5,6 The Liwan Eye study in China reported a mean IOP reduction of 3 mmHg and increase in anterior chamber angle width of 2 units in Shaffer angle grade, 2 weeks post-LPI. 6 By contrast, a Vietnamese study with a longer mean follow-up time of 12 years reported 22.2 % of patients with PACS progressed to PAC despite LPI. 7 The need for additional intervention to control IOP after LPI for PAC, especially in PACG, has been a relatively consistent finding in various studies. Peng et al. reported 42.2 % of PAC and all PACG required additional interventions to control IOP. 7 Cumba et al. also reported a significant ...